Silencing VDAC1 to Treat Mesothelioma Cancer: Tumor Reprograming and Altering Tumor Hallmarks.

Pandey, Swaroop Kumar; Machlof-Cohen, Renen; Santhanam, Manikandan; Shteinfer-Kuzmine, Anna; Shoshan-Barmatz, Varda

Pandey, Swaroop Kumar; Machlof-Cohen, Renen; Santhanam, Manikandan; Shteinfer-Kuzmine, Anna; Shoshan-Barmatz, Varda.

Afiliação

Pandey SK; Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Machlof-Cohen R; The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Santhanam M; Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Shteinfer-Kuzmine A; Department of Life Sciences, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.
Shoshan-Barmatz V; The National Institute for Biotechnology in the Negev, Ben-Gurion University of the Negev, Beer-Sheva 84105, Israel.

Biomolecules ; 12(7)2022 06 27.

Article em En | MEDLINE | ID: mdl-35883451

Assuntos

Mesotelioma; Nanotubos de Carbono; Animais; Apoptose; Humanos; Inflamação; Mesotelioma/genética; Mesotelioma/terapia; Camundongos; RNA Interferente Pequeno/metabolismo; Microambiente Tumoral; Canal de Ânion 1 Dependente de Voltagem/genética; Canal de Ânion 1 Dependente de Voltagem/metabolismo

Palavras-chave

VDAC1; mesothelioma; metabolism; mitochondria

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Nanotubos de Carbono / Mesotelioma Limite: Animals / Humans Idioma: En Revista: Biomolecules Ano de publicação: 2022 Tipo de documento: Article País de afiliação: Israel

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google